Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Coronary Thrombosis | 5 | 2019 | 433 | 1.42 | Why? |
| Percutaneous Coronary Intervention | 16 | 2019 | 3646 | 1.33 | Why? |
| Angioplasty, Balloon, Coronary | 3 | 2019 | 365 | 1.24 | Why? |
| Stents | 5 | 2019 | 916 | 1.22 | Why? |
| Troponin C | 1 | 2020 | 29 | 0.88 | Why? |
| Coronary Artery Disease | 11 | 2019 | 2570 | 0.87 | Why? |
| Drug-Eluting Stents | 8 | 2019 | 562 | 0.82 | Why? |
| Coronary Occlusion | 2 | 2018 | 138 | 0.79 | Why? |
| Angina, Stable | 1 | 2019 | 45 | 0.77 | Why? |
| Coronary Angiography | 12 | 2019 | 2275 | 0.76 | Why? |
| Cardiac Catheters | 1 | 2018 | 44 | 0.73 | Why? |
| Tomography, Optical Coherence | 9 | 2019 | 1008 | 0.70 | Why? |
| Coronary Stenosis | 2 | 2018 | 273 | 0.70 | Why? |
| Graft Occlusion, Vascular | 1 | 2018 | 105 | 0.68 | Why? |
| Aorta, Abdominal | 1 | 2017 | 50 | 0.67 | Why? |
| Vascular Patency | 1 | 2017 | 96 | 0.67 | Why? |
| Iliac Artery | 1 | 2017 | 50 | 0.67 | Why? |
| Catheterization, Peripheral | 2 | 2017 | 249 | 0.65 | Why? |
| Plaque, Atherosclerotic | 5 | 2019 | 423 | 0.64 | Why? |
| Soccer | 1 | 2020 | 259 | 0.63 | Why? |
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 206 | 0.62 | Why? |
| Exercise Test | 1 | 2021 | 911 | 0.56 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.55 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.53 | Why? |
| Platelet Aggregation Inhibitors | 3 | 2020 | 1671 | 0.52 | Why? |
| ST Elevation Myocardial Infarction | 6 | 2021 | 3051 | 0.51 | Why? |
| Athletes | 1 | 2020 | 1047 | 0.48 | Why? |
| Coronary Artery Bypass | 1 | 2018 | 629 | 0.47 | Why? |
| Fractional Flow Reserve, Myocardial | 3 | 2018 | 173 | 0.46 | Why? |
| Coronary Vessels | 4 | 2019 | 914 | 0.42 | Why? |
| Acute Coronary Syndrome | 6 | 2019 | 2107 | 0.36 | Why? |
| Femoral Artery | 3 | 2019 | 213 | 0.35 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.33 | Why? |
| Prosthesis Design | 5 | 2019 | 594 | 0.29 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| Anticoagulants | 4 | 2020 | 9563 | 0.27 | Why? |
| Coated Materials, Biocompatible | 1 | 2004 | 113 | 0.25 | Why? |
| Coronary Aneurysm | 1 | 2004 | 132 | 0.23 | Why? |
| Aspirin | 2 | 2020 | 1043 | 0.22 | Why? |
| Follow-Up Studies | 10 | 2021 | 17020 | 0.20 | Why? |
| Heart-Assist Devices | 2 | 2018 | 812 | 0.20 | Why? |
| Popliteal Artery | 1 | 2019 | 32 | 0.20 | Why? |
| Radial Artery | 2 | 2017 | 132 | 0.19 | Why? |
| Hyaluronoglucosaminidase | 1 | 2018 | 18 | 0.19 | Why? |
| Gastrostomy | 1 | 2019 | 56 | 0.19 | Why? |
| Treatment Outcome | 15 | 2020 | 51732 | 0.19 | Why? |
| Aneurysm, Dissecting | 1 | 2004 | 303 | 0.19 | Why? |
| Heart Ventricles | 2 | 2018 | 1139 | 0.19 | Why? |
| Ultrasonography, Interventional | 1 | 2004 | 560 | 0.19 | Why? |
| Heart Failure | 5 | 2021 | 6638 | 0.18 | Why? |
| Coronary Vessel Anomalies | 1 | 2019 | 87 | 0.18 | Why? |
| Gastroscopy | 1 | 2019 | 112 | 0.18 | Why? |
| Italy | 14 | 2021 | 38444 | 0.18 | Why? |
| Fibrinolytic Agents | 2 | 2021 | 1702 | 0.18 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 193 | 0.18 | Why? |
| Amyloidosis | 1 | 2020 | 178 | 0.18 | Why? |
| Angiography, Digital Subtraction | 1 | 2017 | 123 | 0.17 | Why? |
| Intra-Aortic Balloon Pumping | 1 | 2018 | 125 | 0.17 | Why? |
| Aortography | 1 | 2017 | 60 | 0.17 | Why? |
| Angina Pectoris | 1 | 2018 | 114 | 0.17 | Why? |
| Suction | 1 | 2019 | 297 | 0.17 | Why? |
| Coronary Restenosis | 1 | 2019 | 153 | 0.17 | Why? |
| Everolimus | 1 | 2019 | 215 | 0.16 | Why? |
| Vascular System Injuries | 1 | 2017 | 91 | 0.16 | Why? |
| Thrombectomy | 2 | 2019 | 2272 | 0.16 | Why? |
| Microcirculation | 2 | 2017 | 447 | 0.16 | Why? |
| Oxygen Consumption | 1 | 2021 | 711 | 0.16 | Why? |
| Myocardial Revascularization | 1 | 2018 | 267 | 0.15 | Why? |
| Monitoring, Intraoperative | 1 | 2017 | 140 | 0.15 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.15 | Why? |
| Vasodilation | 1 | 2018 | 258 | 0.15 | Why? |
| Long Term Adverse Effects | 1 | 2017 | 119 | 0.15 | Why? |
| Muscular Dystrophy, Duchenne | 1 | 2017 | 129 | 0.15 | Why? |
| Atrial Fibrillation | 2 | 2021 | 2320 | 0.15 | Why? |
| Aged | 30 | 2021 | 215776 | 0.15 | Why? |
| Cell Adhesion Molecules | 1 | 2018 | 472 | 0.15 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.14 | Why? |
| Infusions, Intravenous | 1 | 2019 | 1224 | 0.14 | Why? |
| Hemorrhage | 4 | 2020 | 3013 | 0.14 | Why? |
| Arterial Occlusive Diseases | 1 | 2019 | 363 | 0.14 | Why? |
| Tissue Plasminogen Activator | 1 | 2021 | 778 | 0.14 | Why? |
| Thiazoles | 1 | 2019 | 496 | 0.14 | Why? |
| Cardiomyopathy, Dilated | 1 | 2017 | 251 | 0.14 | Why? |
| Factor Xa Inhibitors | 1 | 2019 | 490 | 0.13 | Why? |
| Secondary Prevention | 1 | 2019 | 762 | 0.13 | Why? |
| Risk Factors | 16 | 2021 | 71621 | 0.13 | Why? |
| Cardiac Catheterization | 2 | 2018 | 882 | 0.13 | Why? |
| Primary Prevention | 1 | 2020 | 778 | 0.13 | Why? |
| Pyridines | 1 | 2019 | 680 | 0.13 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.12 | Why? |
| Disease Management | 3 | 2020 | 6841 | 0.12 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2018 | 663 | 0.12 | Why? |
| Microvessels | 1 | 2017 | 490 | 0.12 | Why? |
| Shock, Cardiogenic | 1 | 2018 | 700 | 0.11 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.11 | Why? |
| Humans | 46 | 2021 | 930598 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Time Factors | 6 | 2019 | 31397 | 0.11 | Why? |
| Vascular Diseases | 1 | 2019 | 846 | 0.10 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.10 | Why? |
| Female | 30 | 2021 | 380317 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Male | 29 | 2021 | 367725 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.10 | Why? |
| Myocardial Infarction | 3 | 2021 | 3361 | 0.10 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.10 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.10 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.10 | Why? |
| Retrospective Studies | 15 | 2021 | 105322 | 0.09 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 839 | 0.09 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Registries | 2 | 2018 | 12327 | 0.09 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.09 | Why? |
| Echocardiography | 1 | 2021 | 3661 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2018 | 2218 | 0.08 | Why? |
| Delirium | 1 | 2017 | 1061 | 0.08 | Why? |
| Prognosis | 9 | 2021 | 32490 | 0.08 | Why? |
| Coronary Circulation | 2 | 2017 | 188 | 0.07 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.07 | Why? |
| Predictive Value of Tests | 5 | 2018 | 9537 | 0.07 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Protective Factors | 2 | 2020 | 1720 | 0.07 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.07 | Why? |
| Rupture, Spontaneous | 1 | 2004 | 115 | 0.07 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.07 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.07 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Acute Disease | 3 | 2021 | 6029 | 0.06 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.05 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2004 | 226 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.05 | Why? |
| Protein Splicing | 1 | 2018 | 2 | 0.05 | Why? |
| Neointima | 1 | 2019 | 39 | 0.05 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 5002 | 0.05 | Why? |
| Self Expandable Metallic Stents | 1 | 2019 | 52 | 0.05 | Why? |
| Survival Rate | 3 | 2018 | 9206 | 0.05 | Why? |
| Hyaluronan Receptors | 1 | 2018 | 61 | 0.05 | Why? |
| Intraoperative Period | 1 | 2018 | 97 | 0.05 | Why? |
| Rupture | 1 | 2017 | 40 | 0.04 | Why? |
| Punctures | 1 | 2017 | 89 | 0.04 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
| Recurrence | 2 | 2018 | 3675 | 0.04 | Why? |
| Heart Arrest | 2 | 2018 | 1239 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2018 | 317 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Heart Function Tests | 1 | 2017 | 101 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Myocardial Reperfusion | 1 | 2017 | 168 | 0.04 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.04 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.04 | Why? |
| Veins | 1 | 2017 | 168 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2020 | 10649 | 0.04 | Why? |
| Rome | 1 | 2017 | 497 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.04 | Why? |
| Equipment Design | 2 | 2018 | 3095 | 0.04 | Why? |
| Myocardial Perfusion Imaging | 1 | 2017 | 218 | 0.03 | Why? |
| Clinical Decision-Making | 2 | 2019 | 3755 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Ventricular Remodeling | 1 | 2017 | 349 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2019 | 1289 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.03 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.03 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2019 | 3228 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Adult | 2 | 2020 | 244371 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Animals | 2 | 2019 | 78931 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Porto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(134)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_